bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.110
-0.040 (-3.48%)
Dec 3, 2024, 1:36 PM EST - Market open
bioAffinity Technologies Employees
bioAffinity Technologies had 75 employees as of December 31, 2023. The number of employees increased by 61 or 435.71% compared to the previous year.
Employees
75
Change (1Y)
61
Growth (1Y)
435.71%
Revenue / Employee
$124,904
Profits / Employee
-$112,615
Market Cap
17.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 75 | 61 | 435.71% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Marinus Pharmaceuticals | 166 |
| Retractable Technologies | 151 |
| Vivos Therapeutics | 123 |
| ProPhase Labs | 113 |
| Lifeward | 108 |
| Cumberland Pharmaceuticals | 91 |
| BioXcel Therapeutics | 74 |
| MEI Pharma | 28 |
BIAF News
- 19 days ago - bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 - Business Wire
- 4 weeks ago - bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development - Business Wire
- 4 weeks ago - bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung - Business Wire
- 6 weeks ago - WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement - PRNewsWire
- 6 weeks ago - bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement - Business Wire
- 6 weeks ago - WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement - PRNewsWire
- 6 weeks ago - bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement - Business Wire
- 6 weeks ago - bioAffinity's CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines - Business Wire